Robeco Institutional Asset Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-68,607
Closed -$922K 904
2024
Q3
$922K Hold
68,607
﹤0.01% 789
2024
Q2
$950K Buy
68,607
+49,539
+260% +$784K ﹤0.01% 777
2024
Q1
$357K Buy
+19,068
New +$381K ﹤0.01% 871
2023
Q2
Sell
-16,001
Closed -$357K 1051
2023
Q1
$357K Hold
16,001
﹤0.01% 878
2022
Q4
$425K Buy
16,001
+12,220
+323% +$399K ﹤0.01% 861
2022
Q3
$107K Sell
3,781
-41,121
-92% -$1.06M ﹤0.01% 877
2022
Q2
$934K Sell
44,902
-3,749
-8% -$70.2K ﹤0.01% 710
2022
Q1
$1.05M Buy
48,651
+28,024
+136% +$608K ﹤0.01% 707
2021
Q4
$572K Buy
20,627
+13,320
+182% +$323K ﹤0.01% 755
2021
Q3
$155K Buy
+7,307
New +$137K ﹤0.01% 860

Other funds holding CCRN

Robeco Institutional Asset Management's CCRN Position: Q4 2024 in Review

Robeco Institutional Asset Management sold out of Cross Country Healthcare (CCRN) in Q4 2024, closing a stake of 68,607 shares — an estimated $922K sold.

Robeco Institutional Asset Management first reported a position in CCRN in Q3 2021 and held it in 10 quarters. The position peaked at $1.05M in Q1 2022. 175 funds tracked by Wall St. Rank hold CCRN as of Q4 2024.

  • Robeco Institutional Asset Management reported no remaining Cross Country Healthcare position as of Q4 2024 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 68,607 Cross Country Healthcare shares in Q4 2024, an estimated $922K.
  • Robeco Institutional Asset Management first reported a position in Cross Country Healthcare in Q3 2021 and held it in 10 quarters.
  • Robeco Institutional Asset Management's Cross Country Healthcare position peaked at $1.05M in Q1 2022.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2024.

Based on Robeco Institutional Asset Management's 13F filing for Q4 2024, filed 23 Jan 2025.